MARKET

ZLAB

ZLAB

Zai Lab Limited
NASDAQ
24.60
-1.44
-5.53%
After Hours: 24.60 0 0.00% 19:30 11/13 EST
OPEN
25.75
PREV CLOSE
26.04
HIGH
25.94
LOW
23.43
VOLUME
1.22M
TURNOVER
--
52 WEEK HIGH
29.02
52 WEEK LOW
15.96
MARKET CAP
2.77B
P/E (TTM)
-13.8039
1D
5D
1M
3M
1Y
5Y
1D
Zai Lab Advances Atopic Dermatitis Candidate Toward Potential Quarterly Maintenance Dosing
Benzinga · 8h ago
Zai Lab Announces Participation in Investor Conferences in November 2026
Barchart · 11h ago
Zai Lab presents first-in-human data from ZL-1503 Phase 1/1b trial
TipRanks · 14h ago
Zai Lab Presents Positive First-in-Human Data for ZL-1503, a Novel IL-13/IL-31Rα Bispecific, Demonstrating Rapid and Sustained Inhibition of Key Atopic Dermatitis Biomarkers and Extended Serum Half-Life Supporting Less Frequent Dosing
Barchart · 20h ago
Consensus Price Target for Zai Lab Limited - Depositary Receipt Increased by 12.10% to $31.30
NASDAQ · 4d ago
Weekly Report: what happened at ZLAB last week (1102-1106)?
Weekly Report · 4d ago
Zai Lab presents updated clinical data on zocilurtatug pelitecan
TipRanks · 11/05 14:17
Zai Lab To Present Updated Data From Phase 1b/2 Trial Of Zocilurtatug Pelitecan Showing Clinically Meaningful, Durable Anti-Tumor Responses In Patients With Previously Treated Advanced Extrapulmonary Neuroendocrine Carcinomas At The North American Neuroendocrine Tumor Society Symposium
Benzinga · 11/05 14:07
More
About ZLAB
Zai Lab Ltd is a holding company primarily engaged in biopharmaceutical business. The Company is focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. The Company has a series of patented drug candidates from the discovery stage to the late clinical project, including ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others. The Company conducts its businesses within domestic and overseas markets.

Webull offers Zai Lab Ltd - ADR stock information, including NASDAQ: ZLAB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ZLAB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ZLAB stock methods without spending real money on the virtual paper trading platform.